Incyte (INCY) Gross Profit (2012 - 2026)
Incyte's Gross Profit was $1.45 billion in Q3 2026, up 14.3% from $1.27 billion a year earlier but down 7.7% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Gross Profit (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Incyte's Gross Profit was $5.57 billion through Sep 30, 2026, up 24.5% year-over-year; for FY2025, it came in at $4.77 billion, up 21.4% from FY2024.
- Gross Profit has now increased for 13 consecutive years, with a five-year compound annual growth rate of 13.5% (FY2020 to FY2025).
- In earlier years, Gross Profit was $3.93 billion in FY2024 (+14.2%), $3.44 billion in FY2023 (+7.9%), $3.19 billion in FY2022 (+12.4%) and $2.84 billion in FY2021 (+11.8%).
- Quarterly Gross Profit has moved between $690.62 million (Q1 2022) and $1.57 billion (Q2 2026) over five years.
- Compared with a year earlier, Gross Profit has increased for 16 straight quarters, with growth averaging 21.5% over the last eight quarters.
- The best year-over-year quarter for Gross Profit over five years was Q2 2026 (growth of 38.0%); the worst was Q3 2022 (a decline of 0.6%).
- Per Business Quant data, INCY's Gross Profit in the three quarters before Q3 2026 was $1.57 billion (Q2 2026), $1.17 billion (Q1 2026) and $1.39 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.45 Bn |
| Jun 30, 2026 | 1.57 Bn |
| Mar 31, 2026 | 1.17 Bn |
| Dec 31, 2025 | 1.39 Bn |
| Sep 30, 2025 | 1.27 Bn |
| Jun 30, 2025 | 1.14 Bn |
| Mar 31, 2025 | 979.71 Mn |
| Dec 31, 2024 | 1.09 Bn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | 967.13 Mn |
| Mar 31, 2024 | 819.93 Mn |
| Dec 31, 2023 | 943.59 Mn |
| Sep 30, 2023 | 858.93 Mn |
| Jun 30, 2023 | 886.28 Mn |
| Mar 31, 2023 | 751.85 Mn |
| Dec 31, 2022 | 867.54 Mn |
| Sep 30, 2022 | 768.72 Mn |
| Jun 30, 2022 | 860.76 Mn |
| Mar 31, 2022 | 690.62 Mn |
| Dec 31, 2021 | 818.98 Mn |
API Access
Incyte Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();